Related Experiment Video
Updated: Jul 19, 2026

Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion
Published on: April 5, 2016
Axon regeneration through scars and into sites of chronic spinal cord injury
Paul Lu1, Leonard L Jones, Mark H Tuszynski
1Department of Neurosciences-0626, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
Abstract:
Cellular and extracellular inhibitors are thought to restrict axon growth after chronic spinal cord injury (SCI), confronting the axon with a combination of chronic astrocytosis and extracellular matrix-associated inhibitors that collectively constitute the chronic "scar." To examine whether the chronically injured environment is strongly inhibitory to axonal regeneration, we grafted permissive autologous bone marrow stromal cells (MSCs) into mid-cervical SCI sites of adult rats, 6 weeks post-injury without resection of the "chronic scar." Additional subjects received MSCs genetically modified to express neurotrophin-3 (NT-3), providing a further local stimulus to axon growth. Anatomical analysis 3 months post-injury revealed extensive astrocytosis surrounding the lesion site, together with dense deposition of the inhibitory extracellular matrix molecule NG2. Despite this inhibitory environment, axons penetrated the lesion site through the chronic scar. Robust axonal regeneration occurred into chronic lesion cavities expressing NT-3. Notably, chronically regenerating axons preferentially associated with Schwann cell surfaces expressing both inhibitory NG2 substrates and the permissive substrates L1 and NCAM in the lesion site. Collectively, these findings indicate that inhibitory factors deposited at sites of chronic SCI do not create impenetrable boundaries and that inhibition can be balanced by local and diffusible signals to generate robust axonal growth even without resecting chronic scar tissue.
Insights
Bone marrow stromal cells (MSCs) promote axon regeneration after spinal cord injury (SCI). Even in the presence of inhibitory scar tissue, MSCs and neurotrophin-3 (NT-3) facilitate significant axonal regrowth, challenging previous notions of SCI barriers.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Spinal Cord Injury Research
Background:
- Chronic spinal cord injury (SCI) creates an inhibitory environment due to astrocytosis and extracellular matrix (ECM) molecules, hindering axon regeneration.
- The chronic
Purpose of the Study:
- To investigate if autologous bone marrow stromal cells (MSCs), with or without neurotrophin-3 (NT-3) expression, can promote axonal regeneration within the inhibitory environment of a chronic SCI scar.
- To determine if axonal regeneration can occur without surgical resection of the chronic scar tissue.
Main Methods:
- Grafting of autologous bone marrow stromal cells (MSCs) into chronic SCI sites in adult rats 6 weeks post-injury.
- Some MSC grafts were genetically modified to express neurotrophin-3 (NT-3).
- Anatomical analysis was performed 3 months post-grafting to assess axonal regeneration and the lesion environment.
Main Results:
- Axons successfully penetrated the chronic scar tissue despite the presence of inhibitory molecules like NG2 and extensive astrocytosis.
- Significant axonal regeneration was observed into lesion cavities expressing NT-3.
- Regenerating axons were found to associate with Schwann cells expressing both inhibitory (NG2) and permissive (L1, NCAM) substrates.
Conclusions:
- Inhibitory factors in chronic SCI scars do not form absolute barriers to axonal regeneration.
- Local and diffusible signals, such as those provided by MSCs and NT-3, can overcome scar-mediated inhibition.
- Robust axonal growth is achievable even in chronic SCI without scar resection, highlighting potential therapeutic strategies.
More Related Videos
Related Concept Videos
Neurogenesis and Regeneration of Nervous Tissue
Overview of Regeneration and Repair
Regeneration
All animals have varying degrees of...
Spinal Cord Injury ll: Pathophysiology
Whole Body Regeneration
Secondary Spinal Cord Injury llI: Pathophysiology

